首页> 美国卫生研究院文献>Journal of Virology >Note: De Novo Initiation of RNA Synthesis by Hepatitis C Virus Nonstructural Protein 5B Polymerase
【2h】

Note: De Novo Initiation of RNA Synthesis by Hepatitis C Virus Nonstructural Protein 5B Polymerase

机译:注意:丙型肝炎病毒非结构蛋白5B聚合酶从头开始RNA合成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

RNA-dependent RNA polymerase (RdRp) encoded by positive-strand RNA viruses is critical to the replication of viral RNA genome. Like other positive-strand RNA viruses, replication of hepatitis C virus (HCV) RNA is mediated through a negative-strand intermediate, which is generated through copying the positive-strand genomic RNA. Although it has been demonstrated that HCV NS5B alone can direct RNA replication through a copy-back primer at the 3′ end, de novo initiation of RNA synthesis is likely to be the mode of RNA replication in infected cells. In this study, we demonstrate that a recombinant HCV NS5B protein has the ability to initiate de novo RNA synthesis in vitro. The NS5B used HCV 3′ X-tail RNA (98 nucleotides) as the template to synthesize an RNA product of monomer size, which can be labeled by [γ-32P]nucleoside triphosphate. The de novo initiation activity was further confirmed by using small synthetic RNAs ending with dideoxynucleotides at the 3′ termini. In addition, HCV NS5B preferred GTP as the initiation nucleotide. The optimal conditions for the de novo initiation activity have been determined. Identification and characterization of the de novo priming or initiation activity by HCV NS5B provides an opportunity to screen for inhibitors that specifically target the initiation step.
机译:正链RNA病毒编码的RNA依赖性RNA聚合酶(RdRp)对病毒RNA基因组的复制至关重要。像其他正链RNA病毒一样,丙型肝炎病毒(HCV)RNA的复制是通过负链中间体介导的,该中间体是通过复制正链基因组RNA产生的。尽管已经证明HCV NS5B单独可以通过3'末端的回写引物指导RNA复制,但是RNA合成的从头开始可能是感染细胞中RNA复制的方式。在这项研究中,我们证明了重组HCV NS5B蛋白具有启动体外RNA合成的能力。 NS5B以HCV 3'X-tail RNA(98个核苷酸)为模板,合成了单体大小的RNA产物,该产物可以用[γ- 32 P]核苷三磷酸标记。通过使用在3'末端以双脱氧核苷酸结尾的小型合成RNA进一步证实了从头开始活性。另外,HCV NS5B优选GTP作为起始核苷酸。从头开始活性的最佳条件已经确定。 HCV NS5B从头启动或启动活性的鉴定和表征为筛选特异性针对启动步骤的抑制剂提供了机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号